Celco acquires new stainless steel finishing equipment
Aims to serve the medical and pharmaceutical Industry
Kansas-based Central Electropolishing Company (Celco) has acquired new electropolishing equipment designed for the medical and pharmaceutical industry.
Medical and pharmaceutical devices and equipment are largely made of stainless steel. The industry maintains established guidelines for its surface finish requirements, calling for the highest standard in surface finishing. Stainless steel finishing through electropolishing has been widely recognised as reducing the opportunity for contamination and is critical to producing and maintaining sterile equipment and systems.
The proper surface finish can reduce product adhesion and improve corrosion resistance, both of which reduce downtime and lower costs.
Benefits of this stainless steel finishing include metal removal, corner rounding, edge sharpening, de-burring and removal of affected zones and micro-cracks. Upon completion, electropolishing results in an enhanced, smoother, bright, shiny surface that is resistant to corrosion.
Electropolishing, the precisely controlled electrolytic removal of metal using an electro-chemical process, mechanically restructures the surface of the metal. By expelling electrons from the exposed surface and causing a smooth reaction, iron is removed and the presence of chromium and nickel is enhanced.
Founded in 1986 by Ken Bellesine, Celco provides stainless steel finishing as well as aluminum electropolishing, passivating and oxygen cleaning and water treatment services.
